Clinical Trial 55526

Doral, FL 33122


Summary:

An Interventional Phase 2/3, Adaptive, Multi-Center, Randomized, Double-Blind Study To
Investigate Efficacy And Safety Of Oral Sisunatovir Compared With Placebo In Non-
Hospitalized Symptomatic Adults With Respiratory Syncytial Virus Infection Who Are At
Risk Of Progression To Severe Illness

 

Criteria:

Older adults and individuals affected by cardiopulmonary comorbidities or compromised immune system are at increased risk of poor clinical outcomes following respiratory syncytial virus (RSV) infection. Currently, no oral treatment is approved for this indication.
The purpose of this trial is to investigate the safety and efficacy of orally administered sisunatovir, a potent inhibitor of the RSV F protein that prevents entry into the host cells, for the treatment of RSV infection in non-hospitalized adults at risk of severe illness.


Qualified Participants May Receive:

Oral Sisunatovir Compared With Placebo


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.